V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10003155 | 10002019 | 0 | 53.4 | Palliative (P) | 2013-09-17 | 2013-09-25 | Gemcitabine weekly | N | N | 10462841 | GEMCITABINE |
| 10003156 | 10002019 | 1.8 | 59.6 | Palliative (P) | 2016-10-23 | 2016-10-23 | ECX | 02 | N | 10462841 | ECX |
| 10003157 | 10002019 | null | 101.9 | null | 2017-03-28 | 2017-03-29 | Cisplatin + Vinorelbine (PO) | N | null | 10462841 | CISPLATIN + VINORELBINE |
| 10003158 | 10002020 | 1.76 | 62.2 | Palliative (P) | null | 2015-07-23 | Hydroxycarbamide | N | N | 10463121 | HYDROXYCARBAMIDE |
| 10003159 | 10002021 | 1.53 | 58.4 | Palliative (P) | 2018-12-08 | 2018-12-22 | Rituximab | N | N | 10463272 | RITUXIMAB |
| 10003160 | 10002021 | 0 | 0 | Disease modification (D) | 2015-10-14 | 2015-10-18 | Hydroxycarbamide | 02 | N | 10463272 | HYDROXYCARBAMIDE |
| 10003161 | 10002022 | 0 | 0 | Disease modification (D) | 2013-11-02 | 2013-11-05 | Hydroxycarbamide | N | Y | 10463447 | HYDROXYCARBAMIDE |
| 10003162 | 10002022 | 1.73 | 0 | Not known (9) | 2016-09-18 | 2016-09-25 | Cisplatin + Vinorelbine (IV) | 02 | N | 10463447 | CISPLATIN + VINORELBINE |
| 10003163 | 10002023 | 1.53 | 66.2 | Palliative (P) | 2017-07-17 | 2017-07-24 | PEMBROLIZUMAB | 02 | N | 10463518 | PEMBROLIZUMAB |
| 10003164 | 10002024 | null | 93 | Disease modification (D) | 2014-11-28 | 2014-11-29 | Hydroxycarbamide | 02 | N | 10463534 | HYDROXYCARBAMIDE |
| 10003165 | 10002025 | null | 69 | Disease modification (D) | 2017-06-16 | 2017-06-29 | Rituximab | N | N | 10463557 | RITUXIMAB |
| 10003166 | 10002026 | 1.75 | 80.1 | Palliative (P) | 2016-09-06 | 2016-09-15 | EOX | 2 | N | 10463565 | EOX |
| 10003167 | 10002027 | 1.71 | null | Palliative (P) | 2017-10-24 | 2017-11-14 | GEMCITABINE | N | N | 10463580 | GEMCITABINE |
| 10003168 | 10006362 | null | 67.9 | Palliative (P) | 2016-01-29 | 2016-01-31 | Trial Unspecified | 01 | N | 10463634 | TRIAL |
| 10003169 | 10006362 | 1.81 | 84.4 | Disease modification (D) | 2015-01-16 | 2015-01-16 | Hydroxycarbamide | N | N | 10463634 | HYDROXYCARBAMIDE |
| 10003170 | 10002028 | 0.72 | 99 | Palliative (P) | 2017-01-10 | 2017-01-14 | Rituximab | N | null | 10463750 | RITUXIMAB |
| 10003171 | 10002029 | 1.67 | 68.6 | Palliative (P) | 2018-04-08 | 2018-04-23 | EOX | N | N | 10463808 | EOX |
| 10003172 | 10002030 | 1.65 | 0 | Palliative (P) | 2014-08-29 | 2014-09-13 | PEMBROLIZUMAB | 02 | N | 10463860 | PEMBROLIZUMAB |
| 10003173 | 10002031 | 1.71 | 62.5 | null | 2016-01-28 | 2016-02-04 | Rituximab | 02 | N | 10463959 | RITUXIMAB |
| 10003174 | 10002032 | 1.53 | 67 | Palliative (P) | 2018-10-23 | 2018-10-25 | Rituximab | N | N | 10464101 | RITUXIMAB |
| 10003175 | 10002032 | 0 | 66 | Disease modification (D) | 2016-05-03 | 2016-05-22 | Hydroxycarbamide | N | N | 10464101 | HYDROXYCARBAMIDE |
| 10003176 | 10002033 | 1.73 | 81 | Palliative (P) | 2017-05-24 | 2017-06-08 | ECX | N | N | 10464258 | ECX |
| 10003177 | 10002033 | null | 0 | Palliative (P) | 2018-02-09 | 2018-02-13 | EOX | 02 | N | 10464258 | EOX |
| 10003178 | 10002034 | 1.7 | 78.6 | Disease modification (D) | 2017-06-27 | 2017-07-01 | Hydroxycarbamide | 02 | N | 10464340 | HYDROXYCARBAMIDE |
| 10003179 | 10002034 | 1.7 | 69.2 | Disease modification (D) | null | 2016-02-03 | Hydroxycarbamide | 02 | N | 10464340 | HYDROXYCARBAMIDE |
| 10003180 | 10002035 | 1.75 | 76.2 | Disease modification (D) | null | 2018-08-28 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 10464403 | GEMCITABINE |
| 10003181 | 10002035 | 1.53 | 48.9 | Palliative (P) | 2015-10-31 | 2015-11-06 | EOX | 02 | N | 10464403 | EOX |
| 10003182 | 10002035 | 1.79 | 63.3 | Palliative (P) | 2018-02-04 | 2018-02-28 | PEMBROLIZUMAB | 02 | N | 10464403 | PEMBROLIZUMAB |
| 10003183 | 10002035 | 0 | 90.85 | Curative (C) | 2017-07-28 | 2017-07-31 | CVP R | 2 | N | 10464403 | CVP R |
| 10003184 | 10002036 | 1.8 | 130 | Curative (C) | 2014-11-23 | 2014-11-23 | R GCVP | N | Y | 10464478 | CVP R |
| 10003185 | 10002037 | 1.72 | 71.2 | Palliative (P) | 2018-01-17 | 2018-01-22 | EOX | N | N | 10464619 | EOX |
| 10003186 | 10002038 | 1.73 | 91.8 | Neo-adjuvant (N) | 2015-11-03 | 2015-11-17 | ECX | 02 | N | 10464716 | ECX |
| 10003187 | 10002038 | 1.69 | 103 | Palliative (P) | 2015-12-22 | 2015-12-25 | CARBOPLATIN + VINORELBINE | 2 | N | 10464716 | CARBOPLATIN + VINORELBINE |
| 10003188 | 10008063 | 1.59 | 66.5 | Palliative (P) | 2015-11-30 | 2015-12-01 | CARBOPLATIN + VINORELBINE | N | null | 10464747 | CARBOPLATIN + VINORELBINE |
| 10003189 | 10008063 | 1.55 | null | Palliative (P) | 2013-12-23 | 2014-01-01 | Gemcitabine weekly | 02 | N | 10464747 | GEMCITABINE |
| 10003190 | 10002039 | 1.78 | 76.3 | Unknown (U) | 2019-07-30 | 2019-08-05 | Rituximab | 02 | N | 10464774 | RITUXIMAB |
| 10003191 | 10002040 | null | null | Disease modification (D) | 2017-11-10 | 2017-11-13 | Trial Unspecified | Y | null | 10464803 | TRIAL |
| 10003192 | 10002040 | 1.54 | 65 | Palliative (P) | 2016-03-19 | 2016-04-03 | EOX | N | N | 10464803 | EOX |
| 10003193 | 10002040 | 1.56 | 59 | Adjuvant (A) | 2016-07-16 | 2016-07-30 | EOX | N | N | 10464803 | EOX |
| 10003194 | 10002040 | 0 | 78.6 | Curative (C) | 2016-10-12 | 2016-10-25 | CVP R | 02 | N | 10464803 | CVP R |
| 10003195 | 10002040 | 1.58 | 57 | Not known (9) | 2018-05-25 | 2018-05-31 | Rituximab | 2 | Y | 10464803 | RITUXIMAB |
| 10003196 | 10002040 | null | 69.9 | Palliative (P) | 2019-05-11 | 2019-05-25 | CARBOPLATIN + VINORELBINE | N | N | 10464803 | CARBOPLATIN + VINORELBINE |
| 10003197 | 10002040 | 0 | 65 | Palliative (P) | 2015-07-29 | 2015-07-29 | Enzalutamide | 2 | N | 10464803 | ENZALUTAMIDE |
| 10003198 | 10002041 | 0 | 78.1 | Disease modification (D) | 2017-03-01 | 2017-03-01 | Hydroxycarbamide | 02 | N | 10465108 | HYDROXYCARBAMIDE |
| 10003199 | 10002042 | 1.74 | 78.6 | Palliative (P) | null | 2015-10-12 | EOX | N | N | 10465117 | EOX |
| 10003200 | 10002043 | 1.78 | 88.8 | Palliative (P) | 2018-02-15 | 2018-02-15 | Enzalutamide | N | N | 10465213 | ENZALUTAMIDE |
| 10003201 | 10002044 | 1.61 | 89.9 | null | 2017-08-06 | 2017-08-08 | Trial Unspecified | 01 | N | 10465225 | TRIAL |
| 10003202 | 10006369 | 1.74 | null | Palliative (P) | 2014-07-31 | 2014-08-24 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 10465264 | GEMCITABINE |
| 10003203 | 10006369 | 1.76 | 107.2 | null | null | 2017-10-06 | Cisplatin + Vinorelbine (IV) | 02 | N | 10465264 | CISPLATIN + VINORELBINE |
| 10003204 | 10002045 | 2 | 64 | Curative (C) | null | 2018-05-29 | Trial Unspecified | N | N | 10465359 | TRIAL |